| Similar Articles |
|---|
 |
The Motley Fool
October 11, 2007
Billy Fisher |
An IPO That Hit the Bull's-Eye Sirtris Pharmaceuticals presents promising drug data and is turning out to be one of the top-performing IPOs in the biotech/pharmaceutical field in 2007.   |
The Motley Fool
January 9, 2008
Brian Orelli |
Sirtris' Diabetes Drug: Safe, but Is It Effective? Sirtris has exciting drugs, but is still a pretty risky investment. Investors, this may be one to keep an eye on. |
The Motley Fool
November 30, 2007
Brian Orelli |
Increased Potency Increases Stock Price Sirtris Pharmaceuticals publishes an article this week in Nature that characterized its discovery of drugs that are 1000 times more potent than resveratrol, the compound found in red wine that makes mice live longer and lowers blood sugar levels in obese mice. |
BusinessWeek
March 20, 2006 |
Biotech's Diet In A Bottle Could Extend Your Life A handful of biotech companies are developing drugs that produce the effects of caloric restriction in the body without depriving people of food. |
The Motley Fool
January 26, 2009
Brian Orelli |
Which One of These Is Not Like the Other? Bristol-Myers and Eli Lilly run into some comparability issues. |
The Motley Fool
April 23, 2008
Brian Lawler |
Glaxo's Three-Quarter-Billion-Dollar Gamble Glaxo adds another development stage drugmaker to its portfolio. Investors take note. |
The Motley Fool
June 23, 2010
Brian Orelli |
Duo of Diabetes Drug Deals Make J&J Better Licensing deals add to Johnson & Johnson's diabetes franchise. |
The Motley Fool
April 29, 2004
Brian Gorman |
Merck, Bristol-Myers Team Up Their agreement to commercialize a diabetes drug reflects intense sales competition in the industry. |
AskMen.com
May 2, 2012 |
Stay Young Have you ever heard of resveratrol? Neither had we. It's the plant compound found in red wine, said to help prevent cancer and diabetes. Now it may even prolong your life. |
Popular Mechanics
March 2008
Glenn Reynolds |
The End of Aging? Inside the New Hunt for a Cure to Growing Old Researchers have started looking into ways to slow, stop or perhaps even reverse the changes that accompany aging. If these scientists succeed, their breakthroughs may lead to major changes in human society. |
Bio-IT World
January 12, 2004
Karen Hopkin |
High-Tech Search for the Fountain of Youth Dramatic advances may help biotechs develop drugs that slow aging. |
The Motley Fool
April 27, 2006
Stephen D. Simpson |
A Sluggish Bristol-Myers Squibb Generic erosion is going to chew away revenue and profits. Investors, at today's prices, there are just too many other better ideas to go after. |
The Motley Fool
July 8, 2008
Brian Lawler |
Blockbuster Drugs Bound for Extinction? One of the biggest classes of prescription drugs, those for diabetes treatments, faces tougher FDA standards. |
AskMen.com
Dustin Driver |
Slow Down Aging For those who are obsessed with youth, there are some things you can do to slow down aging. |
AskMen.com
September 11, 2014
Chris Riddell |
The Anti-Aging Diet Here are 31 foods every guy should be eating to stay young. |
The Motley Fool
December 12, 2008
Brian Orelli |
A Long-Term Play for Your Port Long-term prospects look better than the near term ones for Eli Lilly and its investors. |
BusinessWeek
March 20, 2006 |
The Guru of Anti-Aging There's plenty doctors can do to control the effects of old age, says a leading light in the anti-aging medical movement. |
Chemistry World
May 2010
Derek Lowe |
Column: In the pipeline The author wonders whether tagging molecules with fluorescent labels for assay is like tracking the members of a shoal of fish by tying each one to a whale. In the pharmaceutical business, our work absolutely lives and dies by assay results. |
The Motley Fool
September 30, 2011
Brian Orelli |
A Drug Market That's 366 Million Strong Diabetes drugs have potential. |
Reason
August 2002
Ronald Bailey |
Forever Young The new scientific search for immortality |
AskMen.com
Alex Santoso |
What You Should Know About Diabetes Not many men understand what diabetes is, why it's very bad for them (it is one of the leading causes of impotence), what they can do to avoid getting it or how to treat it. |
Chemistry World
February 12, 2014
Graham Wynne |
Introduction to biological and small molecule drug research and development This text, edited by Ganellin and others, will be of particular interest both to the medicinal chemist who is looking to increase their knowledge beyond the small molecules area, and those with experience in the biologics field. |
BusinessWeek
August 26, 2010
Bess Levin |
The Old and the Beautiful How the boomers' fear of mortality became an $88 billion annual industry is described in Arlene Weintraub's book, Selling the Fountain of Youth: How the Anti-Aging Industry Made a Disease Out of Getting Old -- And Made Billions |
